Global Medical Affairs Leader, Obesity

AstraZeneca is advancing a tailored approach to Obesity and Weight Management, uniting science, medical and commercial excellence to deliver durable outcomes, reduce cardiometabolic risk and protect organs. Our pipeline is moving with purpose and includes next generation oral and injectable therapies that prioritises tolerability, durability and quality of life. Are you ready to be at the forefront of medical innovation? As the Global Medical Affairs Leader for Obesity, you'll play a pivotal role in shaping the future of obesity care. This is your chance to use your expertise to make a real impact on patients' lives. Join us in our mission to transform the patient journey, from prevention to diagnosis, and beyond. 

Accountabilities 

In this dynamic role, you'll be responsible for providing medical leadership across the entire product lifecycle. You'll advise on Research & Development investment decisions, lead pre-launch scientific efforts, and accelerate evidence-based healthcare changes in the real world. Your networking and influencing skills will be key as you facilitate cross-functional collaboration and drive innovation. Are you ready to take on this challenge? 

Role Summary: 

Reporting directly to the Medical Head of Weight Management and T2D, the GMAL is a key strategic business role, with the ability to combine their unique medical expertise with insights from markets, healthcare professionals, patients, and health systems to develop and execute world-class medical strategies for AstraZeneca medicines and market-shaping teams globally.   

As a key member of the Global Medical Team (GMT) within a specific brand and/or disease area, the GMAL serves as a strategic partner and leader, working across the medical enterprise, R&D, and commercial functions. The GMAL is pivotal in bridging the Global Product Team (GPT) and Regional Medical teams (US, EU-Canada, International) and major markets, ensuring alignment to the needs of marketing company affiliates, healthcare professionals, and patients through ambitious global product and disease area strategies. The GMAL enables affiliates worldwide to deliver outstanding product launches, transform health systems, conduct practice-defining studies and real-